The Road to Recovery. This synthesis report is based on three national studies on the evolution of the Ebola epidemic and its impact on Guinea, Liberia and Sierra Leone
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
Pre-Publication draft version. Lat reviewed on 7th July 2017
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more
A paper presented at the 10th International Congress on Infectious Disease, Singapore
Statistical Report No 24: 2014
This new plan has been developed to build on successes made and lessons learnt from implementation of the two initial plans and to provide a short to medium term strategic anchor against which preparedness and response plans to the corona virus disease COVID-19 epidemic in the country should focus o...n for the period June 2021 to June 2022.
more